These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26369532)

  • 1. Computational investigation of molecular mechanism and neuropathological implications in Huntington disease.
    Gopalakrishnan C; Kalsi N; Jethi S; Purohit R
    Mol Cell Biochem; 2015 Nov; 409(1-2):1-11. PubMed ID: 26369532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical Aspect of Huntingtin Protein During polyQ: An In Silico Insight.
    Gopalakrishnan C; Jethi S; Kalsi N; Purohit R
    Cell Biochem Biophys; 2016 Jun; 74(2):129-39. PubMed ID: 27094178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
    Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
    Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein-Protein Interactions of Huntingtin in the Hippocampus].
    Proskura AL; Vechkapova SO; Zapara TA; Ratushniak AS
    Mol Biol (Mosk); 2017; 51(4):734-742. PubMed ID: 28900094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation in Huntington's disease: insights through modelling.
    Cajavec B; Bernard S; Herzel H
    Genome Inform; 2005; 16(1):262-71. PubMed ID: 16362929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant palmitoylation in Huntington disease.
    Sanders SS; Hayden MR
    Biochem Soc Trans; 2015 Apr; 43(2):205-10. PubMed ID: 25849918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.
    Xiao G; Fan Q; Wang X; Zhou B
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14995-5000. PubMed ID: 23980182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex.
    Huang B; Guo Q; Niedermeier ML; Cheng J; Engler T; Maurer M; Pautsch A; Baumeister W; Stengel F; Kochanek S; Fernández-Busnadiego R
    Structure; 2021 Aug; 29(8):804-809.e5. PubMed ID: 33909994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Biology of Huntingtin.
    Saudou F; Humbert S
    Neuron; 2016 Mar; 89(5):910-26. PubMed ID: 26938440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons.
    Zala D; Colin E; Rangone H; Liot G; Humbert S; Saudou F
    Hum Mol Genet; 2008 Dec; 17(24):3837-46. PubMed ID: 18772195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
    Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
    J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
    Bithell A; Johnson R; Buckley NJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
    Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
    Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates.
    Sittler A; Wälter S; Wedemeyer N; Hasenbank R; Scherzinger E; Eickhoff H; Bates GP; Lehrach H; Wanker EE
    Mol Cell; 1998 Oct; 2(4):427-36. PubMed ID: 9809064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.
    Arndt JR; Chaibva M; Legleiter J
    Biomol Concepts; 2015 Mar; 6(1):33-46. PubMed ID: 25741791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putting huntingtin "aggregation" in view with windows into the cellular milieu.
    Hatters DM
    Curr Top Med Chem; 2012; 12(22):2611-22. PubMed ID: 23339311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
    Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction with polyglutamine-expanded huntingtin alters cellular distribution and RNA processing of huntingtin yeast two-hybrid protein A (HYPA).
    Jiang YJ; Che MX; Yuan JQ; Xie YY; Yan XZ; Hu HY
    J Biol Chem; 2011 Jul; 286(28):25236-45. PubMed ID: 21566141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.